DDrare: Database of Drug Development for Rare Diseases

Searched query = "Mitochondrial disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Bupropion; Caffeine; CoenzymeQ10; Cysteamine; Cysteamine Bitartrate; Dexmedetomidine; Dextromethorphan; EPI-743; Elamipretide; Elamipretide (high dose); Elamipretide (intermediate dose); Elamipretide (low dose); Flurbiprofen; Fluzone; Fluzone®; KH176; KL1333; Low Residue Diet Intervention; Midazolam; Midazolam injection; Omeprazole; Propofol; RG2133 (2',3',5'-tri-O-acetyluridine); Repaglinide; SPP-004; Sevoflurane; Sonlicromanol; Tri-O-acetyluridine; Vatiquinone

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00432744 (ClinicalTrials.gov)	January 2007	6/2/2007	Phase III Trial of Coenzyme Q10 in Mitochondrial Disease	Phase 3 Trial of Coenzyme Q10 in Mitochondrial Disease	Mitochondrial Diseases	Drug: CoenzymeQ10;Drug: Placebo	University of Florida	FDA Office of Orphan Products Development;Food and Drug Administration	Completed	12 Months	17 Years	All	24	Phase 3	United States;Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00432744
(ClinicalTrials.gov)

January 2007

6/2/2007

Phase III Trial of Coenzyme Q10 in Mitochondrial Disease

Phase 3 Trial of Coenzyme Q10 in Mitochondrial Disease

Mitochondrial Diseases

Drug: CoenzymeQ10;Drug: Placebo

University of Florida

FDA Office of Orphan Products Development;Food and Drug Administration

Completed

12 Months

17 Years

All

Phase 3

United States;Canada